|
SHARON STONE TO RECEIVE THE ELIZABETH
TAYLOR LEGACY AWARD AT THE INAUGURAL ELIZABETH TAYLOR
BALL TO END AIDS
ON APRIL 30, 2020
Event Presented by Gilead Sciences and
BVLGARI
The
Elizabeth Taylor AIDS Foundation (ETAF)
today announced that Golden Globe® and EMMY® Award-winning actress,
producer, activist and humanitarian Sharon Stone will
receive the Elizabeth Taylor Legacy Award at the
Foundation’s inaugural fundraising gala The Elizabeth
Taylor Ball to End AIDS on April 30, 2020. The gala will
be held on the backlot of Fox Studios and will be generously
supported by title sponsors Gilead Sciences and BVLGARI.
The Elizabeth Taylor Legacy Award recognizes profound
leadership in the fight against HIV and AIDS, recognizing
individuals who have historically committed themselves to
helping those affected by HIV and AIDS through various
efforts from arts to policy to activism. The award honors
the memory of Elizabeth Taylor’s legacy of compassion and
courage while on the forefront of the movement to help
people affected by HIV.
“I started my quest for a vaccine and a cure at the request
of Elizabeth Taylor when she asked me to fill in for her at
amfAR for one night in Cannes. That one night became a
22-year commitment of HIV/AIDS work, study, and fundraising
around the globe and a full understanding of what commitment
itself means,” said Stone. “I ask all of you to join me in
not only honoring this path which Elizabeth forged, but one
which we as committed humanitarians must end. 770,000 people
died of HIV/AIDS last year and one person every three
seconds STILL gets HIV/AIDS. Please help us end Elizabeth’s
brave and incredibly daring and loving task and celebrate
that commitment to life!”
Off screen, Stone’s charitable foundations have given life
and hope to people around the world. At the United Nations
on World AIDS Day 1995, Stone accepted an invitation to
serve for three years as Chairwoman of amfAR’s Campaign for
AIDS Research. In 1998, as her term was coming to a close,
Stone renewed her support of amfAR’s vital innovative
research programs by vowing to continue as campaign chairman
until a safe and effective AIDS vaccine was developed. Since
accepting this key position with amfAR, Stone travelled
nationally and internationally on behalf of the Foundation
and was their Global Chairman for Campaign Fundraising. She
has worked tirelessly to heighten awareness of HIV/AIDS as a
threat to social and economic stability, and to underscore
the urgent needs for continued AIDS research. Stone is
dedicated to this cause, helping to raise hundreds of
millions of dollars for the battle against AIDS.
Past recipients of the Elizabeth Taylor Legacy Award
include Michael Jackson (2018), Elton John (2017), Whoopi
Goldberg (2016), Nancy Pelosi (2015) and Aileen Getty
(2014).
The inaugural Elizabeth Taylor Ball to End AIDS will
include a seated dinner for 350 guests, an exciting live
auction featuring unique works of art and luxury experiences
with Andrea Fiuczynski serving as auctioneer, live
performance, and dancing. Guests will also be given a
first-time up-close look at exclusive items from The
Elizabeth Taylor Archive including highlights from Elizabeth
Taylor’s personal life, film career, and humanitarian
legacy.
The Ball Committee includes ETAF Ambassador Lyn Rothman,
Andrea Fiuczynski, Martine Laing, Jean-Christophe Laizeau,
Kay Saatchi, Begum Sen, Pate Stevens and Yi Zhou.
Also sponsoring the event is American Airlines, ETAF’s
official airline.
ABOUT ETAF
Working tirelessly on the AIDS crisis throughout the 1980s,
Elizabeth Taylor established The Elizabeth Taylor AIDS
Foundation (ETAF) in 1991 to carry out her vision for an
AIDS-free world. ETAF works to provide the direct care
needed for people living with and affected by HIV and AIDS.
Emphasizing Elizabeth’s commitment and concentration on
marginalized communities, ETAF’s work has expanded to ensure
that HIV prevention education and access to treatment is
available through domestic and international initiatives. We
now have the necessary tools to stop the spread of HIV and
end the AIDS crisis with sufficient resources.
www.etaf.org
ABOUT GILEAD SCIENCES
Gilead Sciences, Inc. is a research-based
biopharmaceutical company that discovers, develops, and
commercializes innovative medicines in areas of unmet
medical need. Gilead is dedicated to transforming and
simplifying care for people with life-threatening illnesses
around the world. We also recognize that it takes more than
medicine to address challenges patients
and communities face in accessing the best possible care,
and we know that passion for scientific discovery alone —
and that Gilead alone — cannot solve these challenges.
Gilead applies the same values of partnership, integrity,
and dedication to our work tackling the social and
structural challenges that patients, healthcare providers
and other partners must overcome to identify and elevate the
best possible solutions.
American Airlines is the official airline of the Elizabeth
Taylor AIDS Foundation.
|